These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 24259224)
1. Arsenic concentration in the urine of patients with Blackfoot disease and Bowen's disease. Lin SM; Chiang CH; Yang MH Biol Trace Elem Res; 1985 Aug; 8(1):11-8. PubMed ID: 24259224 [TBL] [Abstract][Full Text] [Related]
2. Arsenic, selenium, and zinc in patients with Blackfoot disease. Lin SM; Yang MH Biol Trace Elem Res; 1988; 15():213-21. PubMed ID: 2484518 [TBL] [Abstract][Full Text] [Related]
3. Reduced burden of Arsenic-Related cancers after water mitigation in Taiwan. Jhuang JR; Lee CH; Chiang CJ; Chen CJ; Lee WC Environ Int; 2024 Mar; 185():108542. PubMed ID: 38461779 [TBL] [Abstract][Full Text] [Related]
4. Concentration of arsenic, selenium, zinc, iron and copper in the urine of blackfoot disease patients at different clinical stages. Wang CT Eur J Clin Chem Clin Biochem; 1996 Jun; 34(6):493-7. PubMed ID: 8831051 [TBL] [Abstract][Full Text] [Related]
5. Trace element concentration and arsenic speciation in the well water of a Taiwan area with endemic blackfoot disease. Chen SL; Yeh SJ; Yang MH; Lin TH Biol Trace Elem Res; 1995 Jun; 48(3):263-74. PubMed ID: 9398946 [TBL] [Abstract][Full Text] [Related]
6. Chemical speciation of arsenic in urine of patients with blackfoot disease. Lin TH; Huang YL Biol Trace Elem Res; 1995 Jun; 48(3):251-61. PubMed ID: 9398945 [TBL] [Abstract][Full Text] [Related]
7. Spontaneous and induced sister chromatid exchanges and delayed cell proliferation in peripheral lymphocytes of Bowen's disease patients and matched controls of arseniasis-hyperendemic villages in Taiwan. Hsu YH; Li SY; Chiou HY; Yeh PM; Liou JC; Hsueh YM; Chang SH; Chen CJ Mutat Res; 1997 Jun; 386(3):241-51. PubMed ID: 9219562 [TBL] [Abstract][Full Text] [Related]
8. Arsenic species in drinking water, hair, fingernails, and urine of patients with blackfoot disease. Lin TH; Huang YL; Wang MY J Toxicol Environ Health A; 1998 Jan; 53(2):85-93. PubMed ID: 9444313 [TBL] [Abstract][Full Text] [Related]
9. [Expression of keratin 16 in normal and lesional skin of solitary and multiple Bowen's disease using monoclonal antibody Ks 8.12 staining]. Sheu HM; Ko SS; Yu HS J Formos Med Assoc; 1991 Dec; 90(12):1252-5. PubMed ID: 1724782 [TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan. Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120 [TBL] [Abstract][Full Text] [Related]
11. Determination of urinary trace elements (As, Hg, Zn, Pb, Se) in patients with Blackfoot disease. Horng CJ; Lin SR Talanta; 1997 Dec; 45(1):75-83. PubMed ID: 18966982 [TBL] [Abstract][Full Text] [Related]
12. Effects and dose--response relationships of skin cancer and blackfoot disease with arsenic. Tseng WP Environ Health Perspect; 1977 Aug; 19():109-19. PubMed ID: 908285 [TBL] [Abstract][Full Text] [Related]
13. Arterial tissue of arsenic, selenium and iron in Blackfoot disease patients. Wang CT; Chang WT Clin Chem Lab Med; 2001 Jul; 39(7):645-8. PubMed ID: 11522114 [TBL] [Abstract][Full Text] [Related]
14. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Tseng CH; Chong CK; Chen CJ; Tai TY Atherosclerosis; 1996 Feb; 120(1-2):125-33. PubMed ID: 8645353 [TBL] [Abstract][Full Text] [Related]
15. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic. Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756 [TBL] [Abstract][Full Text] [Related]
16. A case of Bowen's disease and small-cell lung carcinoma: long-term consequences of chronic arsenic exposure in Chinese traditional medicine. Lee L; Bebb G Environ Health Perspect; 2005 Feb; 113(2):207-10. PubMed ID: 15687059 [TBL] [Abstract][Full Text] [Related]
17. Determination of urinary trace elements (arsenic, copper, cadmium, manganese, lead, zinc, selenium) in patients with Blackfoot disease. Tsai JL; Horng PH; Hwang TJ; Hsu JW; Horng CJ Arch Environ Health; 2004 Dec; 59(12):686-92. PubMed ID: 16789478 [TBL] [Abstract][Full Text] [Related]
18. The role of oxidative DNA damage in human arsenic carcinogenesis: detection of 8-hydroxy-2'-deoxyguanosine in arsenic-related Bowen's disease. Matsui M; Nishigori C; Toyokuni S; Takada J; Akaboshi M; Ishikawa M; Imamura S; Miyachi Y J Invest Dermatol; 1999 Jul; 113(1):26-31. PubMed ID: 10417614 [TBL] [Abstract][Full Text] [Related]
19. Merkel cell carcinoma and multiple Bowen's disease: incidental association or possible relationship to inorganic arsenic exposure? Ohnishi Y; Murakami S; Ohtsuka H; Miyauchi S; Shinmori H; Hashimoto K J Dermatol; 1997 May; 24(5):310-6. PubMed ID: 9198320 [TBL] [Abstract][Full Text] [Related]
20. Arsenic-related Bowen's disease, palmar keratosis, and skin cancer. Cöl M; Cöl C; Soran A; Sayli BS; Oztürk S Environ Health Perspect; 1999 Aug; 107(8):687-9. PubMed ID: 10417369 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]